East Windsor, NJ — Sabinsa has been granted a U.S. patent on the company’s shelf stable probiotic LactoSpore in combination with cranberry seed fibers.
Patent No. US9717766 discloses a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 in a synbiotic composition containing natural plant fibers from Vaccinium oxycoccos, otherwise known as cranberry. The cranberry fibers in this composition were observed to increase the viable count of Bacillus coagulans MTCC 5856.
This combination product is sold under the name LactoCran, with the cranberry seed fiber components supplied by Fruit d’Or Nutraceuticals of Quebec, Canada. LactoCran provides support for healthy gut and digestive health. The non-lactose, dairy-free, non-GMO combination works well in sports nutrition supplements as it contains a rich composition of 16 essential amino acids and 8 branch chain amino acids.
Sabinsa was granted a patent earlier this year on use of LactoSpore for the management of Irritable Bowel Syndrome. The probiotic is room temperature stable and does not require refrigeration.